Hikma signs licensing, distribution agreement with Perrigo

Hikma signs licensing, distribution agreement with Perrigo

5:33 AM, 10th July 2018
Hikma  logo

LONDON, UK: Hikma Pharmaceuticals PLC (Hikma) has signed a licensing and distribution agreement with Omega Pharma Trading NV, an affiliate of Perrigo Company plc (Perrigo), one of the largest providers of over-the-counter healthcare solutions in Europe.

Under the terms of the agreement, Hikma has the exclusive right to license and distribute more than 30 consumer healthcare products, including Davitamon, Prevalin, XLS Medical, Dermalex and Paranix, in all its MENA markets, with the exception of current agreements in place. Hikma aims to work with Perrigo’s existing partners in the MENA region to broaden sales and marketing coverage.

In addition, Hikma has the right of first refusal to the full range of Perrigo’s OTC medicines in the region.

The partnership provides a significant opportunity for Hikma to collaborate with Perrigo in MENA, building on the strengths of each company. The agreement will leverage Hikma’s substantial local presence with operations in 17 markets and an established sales and marketing team, experienced in building brands, with particular expertise in the consumer health business.

“We are very pleased to be entering a partnership with Perrigo. This agreement will expand our consumer healthcare portfolio, enabling us to meet growing demand across the region,” said Mazen Darwazah, executive vice chairman, chief executive of MENA and Emerging Markets, Hikma.

“These OTC medicines are important in meeting the healthcare needs of patients and consumers. We are pleased to partner with Hikma to leverage their strong presence in MENA markets, further increasing access to these valuable consumer products,” added Svend Andersen, Perrigo executive vice president and president, consumer healthcare international.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

BASF signs MoU for second Verbund site in China

LUDWIGSHAFEN, GERMANY: BASF SE is investigating the possibility of building a highly-integrated “Verbund” chemical production site in the ...

Read more
Skin challenges awareness, pharma demand to drive market

Glycerin Market size is expected to grow significantly in the coming years owing to its properties such as colorless, odorless, transparent viscous li ...

Read more
Rapid industrialization propels growth

Market Overview Industrial gases are supplied in a range of different cylinders depending on the properties of the gas. Some are delivered at high pr ...

Read more
Rise in global construction activities to drive market growth

Introduction Specialty Lubricants are multi-functional and superior quality lubricants, majorly produced using advanced technologies and high class r ...

Read more
Onshore, offshore exploration initiatives to boost market

The increasing population have augmented the energy requirements of the country. In order to cope with energy demands more Oil and Gas E&P initiat ...

Read more
Trends shaping the personal care industry

According to a report by Indian Beauty & Hygiene Association (IBHA), the beauty and personal care (BPC) segment in India is expected to touch $10 ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X